 | Up a level |
Journal Article
Gross, Oliver, Toenshoff, Burkhard, Weber, Lutz T., Pape, Lars, Latta, Kay, Fehrenbach, Henry, Lange-Sperandio, Baerbel, Zappel, Hildegard, Hoyer, Peter, Staude, Hagen, Koenig, Sabine, John, Ulrike, Gellermann, Jutta, Hoppe, Bernd, Galiano, Matthias, Hoecker, Britta, Ehren, Rasmus, Lerch, Christian, Kashtan, Clifford E., Harden, Markus, Boeckhaus, Jan and Friede, Tim (2020). A multicenter, randomized, placebo -controlled, double-blind phase 3 trial with open -arm comparison indicates safety and ef fi cacy of nephroprotective therapy with ramipril in children with Alport ? s syndrome see commentary. Kidney Int., 97 (6). S. 1275 - 1287. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1755
Okorn, Christine, Goertz, Anne, Vester, Udo, Beck, Bodo B., Bergmann, Carsten, Habbig, Sandra, Koenig, Jens, Konrad, Martin, Mueller, Dominik, Oh, Jun, Ortiz-Bruechle, Nadina, Patzer, Ludwig, Schild, Raphael, Seeman, Tomas, Staudeu, Hagen, Thumfart, Julia 
ORCID: 0000-0003-1162-5295, Toenshoff, Burkhard, Walden, Ulrike, Weber, Lutz, Zaniew, Marcin, Zappel, Hildegard, Hoyer, Peter F. and Weber, Stefanie
(2019).
HNF1B nephropathy has a slow-progressive phenotype in childhood-with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry.
Pediatr. Nephrol., 34 (6).
S. 1065 - 1076.
NEW YORK:
SPRINGER.
ISSN 1432-198X